Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Health Science Reports|December 5, 2024
Risk Evaluation and Mitigation Strategies for Potential Outbreaks of Nipah Virus Infection: Evidenced by the Recent Incidences in Southeast Asian CountriesMd Ashrafur Rahman, Yeasna Shanjana, Sydney Cronmiller, et al.Health Equity|March 6, 2023
Improvement in Hypertension Control Among Adults Seen in Federally Qualified Health Center Clinics in the Stroke Belt: Implementing a Program with a Dashboard and Process MetricsEdward M Behling, Tammy Garris, Vicky Blankenship, et al.Nursing Open|October 21, 2024
Mutated Adenovirus Attacks in West Bengal, India: Risk Evaluation of Multi-Country Outbreaks and Mitigation StrategiesMd Ashrafur Rahman, Sydney Cronmiller, Julianne Ernest, et al.Journal of Medicinal Chemistry|July 22, 2020
GSK789: A Selective Inhibitor of the First Bromodomains (BD1) of the Bromo and Extra Terminal Domain (BET) ProteinsRobert J Watson, Paul Bamborough, Heather Barnett, et al.Nature|December 10, 2025
Earliest evidence of making fireRob Davis, Marcus Hatch, Sally Hoare, et al.Journal of Medicinal Chemistry|July 14, 2021
Optimization of a Series of 2,3-Dihydrobenzofurans as Highly Potent, Second Bromodomain (BD2)-Selective, Bromo and Extra-Terminal Domain (BET) InhibitorsSimon C C Lucas, Stephen J Atkinson, Chun-Wa Chung, et al.Journal of Medicinal Chemistry|January 7, 2022
Design, Synthesis, and Characterization of I-BET567, a Pan-Bromodomain and Extra Terminal (BET) Bromodomain Oral CandidatePhilip G Humphreys, Stephen J Atkinson, Paul Bamborough, et al.The Lancet Regional Health. Europe|April 21, 2025
Safety and efficacy of combined portal and hepatic vein embolisation in patients with colorectal liver metastases (DRAGON1): a multicentre, single-arm clinical trialRemon Korenblik, Sinéad James, Jens Smits, et al.Pageof 2